![Stefan Abele](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Abele
Chief Tech/Sci/R&D Officer at
PHARVARIS N.V.
Net worth: 1 M $ as of 31/07/2026
Profile
Stefan Abele currently works at Pharvaris NV, as Chief Technical Operations Officer from 2023.
Dr. Abele received his doctorate degree from Swiss Federal Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARVARIS N.V. 0.05% | 15/05/2026 | 35,194 ( 0.05% ) | 1 M $ | 31/07/2026 |
Stefan Abele active positions
| Companies | Position | Start |
|---|---|---|
| PHARVARIS N.V. | Chief Tech/Sci/R&D Officer | 15/11/2023 |
Training of Stefan Abele
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
- Stock Market
- Insiders
- Stefan Abele
